Terms: = Liver cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Prognosis
161 results:
1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. Early Onset Intrahepatic Cholangiocarcinoma: Clinical Characteristics, Oncological Outcomes, and Genomic/Transcriptomic Features.
Tsilimigras DI; Han X; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Chaucy F; Koerkamp BG; Endo I; Sasaki K; Aucejo F; Zhang XF; Zhu H; Pawlik TM
Ann Surg Oncol; 2024 May; 31(5):3087-3097. PubMed ID: 38347332
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
4. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal cancer Patients: An Exploratory Study.
Cayún JP; Cerpa LC; Colombo A; Cáceres DD; Leal JL; Reyes F; Gutiérrez-Cáceres C; Calfunao S; Varela NM; Quiñones LA
Curr Oncol; 2024 Jan; 31(1):274-295. PubMed ID: 38248103
[TBL] [Abstract] [Full Text] [Related]
5. Local treatment of liver metastasis in a patient with advanced malignant melanoma: A case report.
Hong H; Shen L; Tan H; Wu Y; Liu Y; Fan W
J Cancer Res Ther; 2023 Dec; 19(6):1675-1679. PubMed ID: 38156937
[TBL] [Abstract] [Full Text] [Related]
6. Regorafenib therapy as a third-line treatment for metastatic colorectal cancer: A single center long term experience.
Ozkan M; Oflazoglu U; Yildiz Y; Güc ZG; Salman T; Ünal S; Kücükzeybek Y; Alacacioglu A
Medicine (Baltimore); 2023 Dec; 102(50):e36435. PubMed ID: 38115370
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
8. The EMT factor ZEB1 paradoxically inhibits EMT in braf-mutant carcinomas.
Sánchez-Tilló E; Pedrosa L; Vila I; Chen Y; Győrffy B; Sánchez-Moral L; Siles L; Lozano JJ; Esteve-Codina A; Darling DS; Cuatrecasas M; Castells A; Maurel J; Postigo A
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870961
[TBL] [Abstract] [Full Text] [Related]
9. A visualized model for identifying optimal candidates for aggressive locoregional surgical treatment in patients with bone metastases from breast cancer.
Tong Y; Xu S; Jiang L; Zhao C; Zhao D
Front Endocrinol (Lausanne); 2023; 14():1266679. PubMed ID: 37867528
[TBL] [Abstract] [Full Text] [Related]
10. Influence of cancer-directed surgery on the prognosis of liver metastases from gastric cancer.
Ji NN; Wu XW; Cao Q; Liu R; Tu W; Zeng YC; Li ZH
Clin Transl Oncol; 2024 Mar; 26(3):756-764. PubMed ID: 37606846
[TBL] [Abstract] [Full Text] [Related]
11. Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi-institutional study.
Liu X; Yue H; Jiang S; Kong L; Xu Y; Chen Y; Wang C; Wang Y; Zhu X; Kong Y; Zhang X; Qian J; Luo Z
Cancer Med; 2023 Aug; 12(15):16163-16172. PubMed ID: 37409486
[TBL] [Abstract] [Full Text] [Related]
12. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
[TBL] [Abstract] [Full Text] [Related]
13. Radiomics in colorectal cancer patients.
Inchingolo R; Maino C; Cannella R; Vernuccio F; Cortese F; Dezio M; Pisani AR; Giandola T; Gatti M; Giannini V; Ippolito D; Faletti R
World J Gastroenterol; 2023 May; 29(19):2888-2904. PubMed ID: 37274803
[TBL] [Abstract] [Full Text] [Related]
14. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
15. Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy.
Ye TW; Wang DD; Lu WF; Xie YM; Xu FQ; Fu TW; Zhang KJ; Liu SY; Xie GL; Cheng J; Jiang K; Xiao ZQ; Yao WF; Shen GL; Liu JW; Huang DS; Zhang CW; Liang L
Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):395-403. PubMed ID: 36939280
[TBL] [Abstract] [Full Text] [Related]
16. Plasmatic braf-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with braf combinatorial treatments.
Ros J; Matito J; Villacampa G; Comas R; Garcia A; Martini G; Baraibar I; Saoudi N; Salvà F; Martin Á; Antista M; Toledo R; Martinelli E; Pietrantonio F; Boccaccino A; Cremolini C; Dientsmann R; Tabernero J; Vivancos A; Elez E
Ann Oncol; 2023 Jun; 34(6):543-552. PubMed ID: 36921693
[TBL] [Abstract] [Full Text] [Related]
17. Real-world treatment and outcomes of patients with metastatic braf mutant colorectal cancer.
Xu T; Li J; Wang Z; Zhang X; Zhou J; Lu Z; Shen L; Wang X
Cancer Med; 2023 May; 12(9):10473-10484. PubMed ID: 36912150
[TBL] [Abstract] [Full Text] [Related]
18. Association of braf Variants With Disease Characteristics, prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma.
Xin HY; Sun RQ; Zou JX; Wang PC; Wang JY; Ye YH; Liu KX; Hu ZQ; Zhou ZJ; Fan J; Zhou J; Zhou SL
JAMA Netw Open; 2023 Mar; 6(3):e231476. PubMed ID: 36867406
[TBL] [Abstract] [Full Text] [Related]
19. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
20. The profile and prognostic value of circulating lymphocyte subsets in metastatic colon cancer.
Xu J; Zhang R; Peng Q; Jia Z; Xiao S; Sun N; Peng M
Int Immunopharmacol; 2023 Apr; 117():109848. PubMed ID: 36812670
[TBL] [Abstract] [Full Text] [Related]
[Next]
